{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:55:14Z","timestamp":1790258114078,"version":"4.1.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015226","name":"Shengjing Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Valproic acid (VPA) is widely used as a major drug in the treatment of epilepsy. Despite the undisputed pharmacological importance and effectiveness of VPA, its potential hepatotoxicity is still a major concern. Being a simple fatty acid, the hepatotoxicity induced by VPA has long been considered to be due primarily to its interference with fatty acid \u03b2-oxidation (\u03b2-FAO). The aim of this study was to investigate the biomarkers for VPA-induced abnormal liver function in epileptic children and to determine potential mechanisms of its liver injury. Targeted metabolomics analysis of acylcarnitines (ACs) was performed in children\u2019s serum. Metabolomic analysis revealed that VPA -induced abnormal liver function resulted in the accumulation of serum long-chain acylcarnitines (LCACs), and the reduced expression of \u03b2-FAO relevant genes (Carnitine palmitoyltrans-ferase (CPT)1, CPT2 and Long-chain acyl-CoA dehydrogenase (LCAD)), indicating the disruption of \u03b2-FAO. As direct peroxisome proliferator-activated receptor <jats:italic>a<\/jats:italic> (PPAR\u03b1)- regulated genes, CPT1A, CPT2 and LCAD were up-regulated after treatment with PPAR\u03b1 agonist, fenofibrate (Feno), indicating the improvement of \u03b2-FAO. Feno significantly ameliorated the accumulation of various lipids in the plasma of VPA-induced hepatotoxic mice by activating PPAR\u03b1, significantly reduced the plasma ACs concentration, and attenuated VPA-induced hepatic steatosis. Enhanced oxidative stress and induced by VPA exposure were significantly recovered using Feno treatment. In conclusion, this study indicates VPA-induced \u03b2-FAO disruption might lead to liver injury, and a significant Feno protective effect against VPA -induced hepatotoxicity through reversing fatty acid metabolism.<\/jats:p>","DOI":"10.3389\/fphar.2022.1048728","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T05:53:42Z","timestamp":1667886822000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["The serum acylcarnitines profile in epileptic children treated with valproic acid and the protective roles of peroxisome proliferator-activated receptor a activation in valproic acid-induced liver injury"],"prefix":"10.3389","volume":"13","author":[{"given":"Yiyi","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaishuai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12011-017-0944-z","article-title":"Zinc deficiency and oxidative stress involved in valproic acid induced hepatotoxicity: Protection by zinc and selenium supplementation","volume":"179","author":"Ahangar","year":"2017","journal-title":"Biol. Trace Elem. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"E3251","DOI":"10.3390\/molecules24183251","article-title":"Carnitine inborn errors of metabolism","volume":"24","author":"Almannai","year":"2019","journal-title":"Molecules"},{"key":"B3","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2013.05.030","article-title":"The metabolomic window into hepatobiliary disease","volume":"59","author":"Beyo\u011flu","year":"2013","journal-title":"J. Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/epi.13011","article-title":"Clinical significance of CYP2C9-status guided valproic acid therapy in children","volume":"56","author":"B\u0171di","year":"2015","journal-title":"Epilepsia"},{"key":"B5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.5414\/cp201735","article-title":"Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose","volume":"50","author":"Buldak","year":"2012","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/liv.13294","article-title":"Old and new treatments for primary biliary cholangitis","volume":"37","author":"Chascsa","year":"2017","journal-title":"Liver Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.2147\/DDDT.S79837","article-title":"Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: A meta-analysis","volume":"9","author":"Chuanyong","year":"2015","journal-title":"Drug Des. devel. Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"781348","DOI":"10.1155\/2013\/781348","article-title":"Effects of three different fibrates on intrahepatic cholestasis experimentally induced in rats","volume":"2013","author":"El-Sisi","year":"2013","journal-title":"PPAR Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1586\/17512433.2014.871202","article-title":"Evidence for a potential protective effect of carnitine-pantothenic acid co-treatment on valproic acid-induced hepatotoxicity","volume":"7","author":"Felker","year":"2014","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e41686","DOI":"10.1371\/journal.pone.0041686","article-title":"Long-chain acylcarnitines regulate the hERG channel","volume":"7","author":"Ferro","year":"2012","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"27239","DOI":"10.1038\/srep27239","article-title":"A metabolomics cell-based approach for anticipating and investigating drug-induced liver injury","volume":"6","author":"Garc\u00eda- Caveras","year":"2016","journal-title":"Sci. Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","volume":"62","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/s0887-8994(97)00026-x","article-title":"Diet- and valproate-induced transient hyperammonemia: Effect of L-carnitine","volume":"16","author":"Gidal","year":"1997","journal-title":"Pediatr. Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejphar.2018.07.057","article-title":"Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer","volume":"835","author":"Heers","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3109\/15376516.2013.821567","article-title":"Toxicity of valproic acid in isolated rat liver mitochondria","volume":"23","author":"Iman","year":"2013","journal-title":"Toxicol. Mech. Methods"},{"key":"B16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.mam.2011.10.008","article-title":"The mitochondrial carnitine\/acylcarnitine carrier: Function, structure and physiopathology","volume":"32","author":"Indiveri","year":"2011","journal-title":"Mol. Asp. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/jat\/20.1.55","article-title":"Valproic acid overdose and L-carnitine therapy","volume":"20","author":"Ishikura","year":"1996","journal-title":"J. Anal. Toxicol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1016\/j.xphs.2016.06.024","article-title":"Effects of carnitine on valproic acid pharmacokinetics in rats","volume":"105","author":"Katayama","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.biochi.2016.12.019","article-title":"The role and regulation of the peroxisome proliferator activated receptor alpha in human liver","volume":"136","author":"Kersten","year":"2017","journal-title":"Biochimie"},{"key":"B20","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.atherosclerosis.2010.10.023","article-title":"Effects of fenofibrate therapy on circulating adipocytokines in patients with primary hypertriglyceridemia","volume":"214","author":"Koh","year":"2011","journal-title":"Atherosclerosis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tox.2015.03.001","article-title":"Sodium valproate induces mitochondrial respiration dysfunction in HepG2 in vitro cell model","volume":"331","author":"Komulainen","year":"2015","journal-title":"Toxicology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"470","DOI":"10.4254\/wjh.v5.i9.470","article-title":"Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease","volume":"5","author":"Kostapanos","year":"2013","journal-title":"World J. Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/15563650902752376","article-title":"Carnitine in the treatment of valproic acid-induced toxicity","volume":"9","author":"Lheureux","year":"2005","journal-title":"Clin. Toxicol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1194\/jlr.M027433","article-title":"Metabolomics reveals an essential role for peroxisome proliferator-activated receptor \u03b1 in bile acid homeostasis","volume":"53","author":"Li","year":"2012","journal-title":"J. Lipid Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/j.1528-1157.1997.tb01263.x","article-title":"Successful treatment by direct hemoperfusion of coma possibly resulting from mitochondrial dysfunction in acute valproate intoxication","volume":"38","author":"Matsumoto","year":"1997","journal-title":"Epilepsia"},{"key":"B26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrendo.2015.129","article-title":"Acylcarnitines-old actors auditioning for new roles in metabolic physiology","volume":"11","author":"Mccoin","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s40263-017-0479-z","article-title":"Dispensability of annual laboratory follow-up after more than 2 Years of valproic acid use: A systematic review","volume":"31","author":"Meijboom","year":"2017","journal-title":"CNS Drugs"},{"key":"B28","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.braindev.2010.12.003","article-title":"Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS\/MS","volume":"33","author":"Nakajima","year":"2011","journal-title":"Brain Dev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13613-022-00984-z","article-title":"L-Carnitine does not improve valproic acid poisoning management: A cohort study with toxicokinetics and concentration\/effect relationships","volume":"12","author":"Nguyen","year":"2022","journal-title":"Ann. Intensive Care"},{"key":"B30","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s13312-018-1322-4","article-title":"Carnitine deficiency in Chinese children with epilepsy on valproate monotherapy","volume":"55","author":"Qiliang","year":"2018","journal-title":"Indian Pediatr."},{"key":"B32","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1345\/aph.19242","article-title":"The role of carnitine supplementation during valproic acid therapy","volume":"34","author":"Raskind","year":"2000","journal-title":"Ann. Pharmacother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/GIM.0b013e3181614289","article-title":"Acylcarnitine profile analysis","volume":"10","author":"Rinaldo","year":"2008","journal-title":"Genet. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev.physiol.64.082201.154705","article-title":"Fatty acid oxidation disorders","volume":"64","author":"Rinaldo","year":"2005","journal-title":"Annu. Rev. Physiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/oby.2008.530","article-title":"Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients","volume":"17","author":"Rosenson","year":"2009","journal-title":"Obes. (Silver Spring)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.mam.2004.06.007","article-title":"Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects","volume":"25","author":"Rubio-Gozalbo","year":"2004","journal-title":"Mol. Asp. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s0009-2797(01)00234-4","article-title":"Differential effect of valproate and its Delta2- and Delta4-unsaturated metabolites, on the beta-oxidation rate of long-chain and medium-chain fatty acids","volume":"137","author":"Silva","year":"","journal-title":"Chem. Biol. Interact."},{"key":"B38","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/s0009-9120(01)00272-7","article-title":"Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS\/MS","volume":"34","author":"Silva","year":"","journal-title":"Clin. Biochem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s10545-009-1126-8","article-title":"Treatment recommendations in long-chain fatty acid oxidation defects: Consensus from a workshop","volume":"32","author":"Spiekerkoetter","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ymgme.2017.07.011","article-title":"Newborn screening for carnitine palmitoyltransferase II deficiency using (C16+C18:1)\/C2: Evaluation of additional indices for adequate sensitivity and lower false-positivity","volume":"122","author":"Tajima","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1194\/jlr.M800221-JLR200","article-title":"Corresponding increase in long-chain acyl-CoA and acylcarnitine after exercise in muscle from VLCAD mice","volume":"50","author":"ter Veld","year":"2009","journal-title":"J. Lipid Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1042\/bj20041489","article-title":"Characterization of carnitine and fatty acid metabolism in the long-chain acyl-CoA dehydrogenase-deficient mouse","volume":"387","author":"van Vlies","year":"2005","journal-title":"Biochem. J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.bbadis.2013.02.012","article-title":"Substrate specificity of human carnitine acetyltransferase: Implications for fatty acid and branched-chain amino acid metabolism","volume":"1832","author":"Violante","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"B44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fcell.2015.00083","article-title":"Metabolic interplay between peroxisomes and other subcellular organelles including mitochondria and the endoplasmic reticulum","volume":"3","author":"Wanders","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ymgmr.2018.03.007","article-title":"Two siblings with very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency suffered from rhabdomyolysis after l-carnitine supplementation","volume":"15","author":"Watanabe","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"33052","DOI":"10.1038\/srep33052","article-title":"Curcumin protects ANIT-induced cholestasis through signaling pathway of FXR-regulated bile acid and inflammation","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"key":"B47","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/bph.13729","article-title":"Schisandrol B protects against cholestatic liver injury through pregnane X receptors","volume":"174","author":"Zeng","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"9967","DOI":"10.1038\/s41598-017-10524-6","article-title":"PPAR\u03b1 activation protects against cholestatic liver injury","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1048728\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T05:53:45Z","timestamp":1667886825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1048728\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":48,"alternative-id":["10.3389\/fphar.2022.1048728"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1048728","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"article-number":"1048728"}}